Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.30p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.75
  • 52 Week Low: 0.95
  • Currency: UK Pounds
  • Shares Issued: 135.47m
  • Volume: 10,065
  • Market Cap: £1.76m
  • RiskGrade: 504

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-23 Interim 0.37 (0.23) (0.15)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 0.72 (0.20) (0.14)p n/a n/a n/a n/a 0.0%
30-Jun-20 0.80 (0.13) (0.09)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 0.60 (0.68) (0.25)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Physiomics Market Data

Currency UK Pounds
Share Price 1.30p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.75
52 Week Low 0.95
Volume 10,065
Shares Issued 135.47m
Market Cap £1.76m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.11% below the market average29.11% below the market average29.11% below the market average29.11% below the market average29.11% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
75.62% below the market average75.62% below the market average75.62% below the market average75.62% below the market average75.62% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Income Not Available
Growth
58.08% below the market average58.08% below the market average58.08% below the market average58.08% below the market average58.08% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

Physiomics Dividends

No dividends found

Trades for 31-May-2024

Time Volume / Share Price
13:38 4,626 @ 1.36p
13:38 5,439 @ 1.23p

Physiomics Key Personnel

CEO Peter Sargent

Top of Page